Theravance Selected Fundamentals

    Theravance Inc -- USA Stock  

     9.81  0.00  0.00%

    The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

    Revenue Analysis

    Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
    Money Received 
    Discounts and Returns 
    38.39 M

    About Revenue

    Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.Compare to competition
    Based on latest financial disclosure Theravance Inc reported 38.39 M of revenue. This is much higher than that of the sector, and significantly higher than that of Revenue industry, The Revenue for all stocks is over 1000% lower than the firm.

    Theravance Inc Fundamental Drivers Relationships

    Theravance Inc is rated fourth in shares outstanding category among related companies. It is rated fourth in earnings per share category among related companies .

    Peer Comparison

    Theravance Return On Asset Comparison
      Return On Asset 
          Theravance Comparables 
    Theravance is currently under evaluation in return on asset category among related companies.

    Did you try this?

    Run Insider Screener Now

    Insider Screener

    Find insiders across different sectors to evaluate their impact on performance
    Hide  View All  Next  Launch Insider Screener